James Hocker to Predictive Value of Tests
                            
                            
                                This is a "connection" page, showing publications James Hocker has written about Predictive Value of Tests.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.387
         
        
        
     
 
    
        
        - 
            Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585.
            
            
                Score: 0.127
             
- 
            Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
            
            
                Score: 0.099
             
- 
            Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer. 2011 Nov; 74(2):206-11.
            
            
                Score: 0.081
             
- 
            Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling. Cancer Invest. 2011 Feb; 29(2):173-9.
            
            
                Score: 0.080